Miscellaneous
Bill Hagstrom is the CEO and Founder of Octave Bioscience, looking at ways to dynamically assess patients with multiple sclerosis and other neurodegenerative diseases to manage their treatment plan better. Bill says, "There's an enormous opportunity to take a personalized approach to managing these patients. MS and these other neurodegenerative diseases are known to have a lot of heterogeneity and have trajectories that can vary dramatically." At the same time, Octave is developing pathway models so a physician can see where a patient is in their overall journey and look at acute decision nodes, and access decision support tools. #OctaveBioscience #personalizedmedicine #MS #multiplesclerosis #neurodegenerativediseases #bloodbasedbiomarkers #biomarkers #symptomology #digitalhealth OctaveBio.com Download the transcript here